jueves, 25 de octubre de 2012

Menos mal que vamos mal (XV): Pharma paga "sustanciales" dividendos



By Fani Kelesidou
Over the years, the drug manufacturing industry has rewarded its investors with substantial dividends. Most major pharmaceuticals have dividend yields in the range between 3.5% and 4.0%. This is more than twice the yield on the 10-year Treasury bonds and well above the yield on the S&P 500. I expect these companies to keep offering substantial dividends.

Here, I review 4 pharmaceuticals, which meet the following criteria:

  • Have a minimum market capitalization of $50 billion. 

  • Have a maximum price-to-earnings ratio of 25.
  • Have a minimum dividend yield of 3.50 percent.

  • Ellas son:

    1. AstraZeneca Group Plc
    2. GlaxoSmithKline
    3. Novartis AG
    4. Sanofi-Aventis



     

    Here I review 5 companies which meet the following criteria:

    • Headquartered in the U.S.
    • Have a minimum market capitalization of $50 billion.
    • Have a maximum price-to-earnings ratio of 25.                                         
    • Have a minimum dividend yield of 3.50 percent.
    Ellas son:
    1.  Bristol-Myers Squibb  
    2. Johnson & Johnson 
    3. Eli Lilly & Co. 
    4. Pfizer Inc.
    5. Merck & Co.

    Ver más

    Ver anterior:
    Menos mal que vamos mal (XIV) / Moody´s Outlook

    Publicar un comentario